Rifaximin is a semisynthetic antibiotic based on rifamycin. It has poor oral bioavailability, meaning that very little of the drug will be absorbed into the bloodstream when it is taken orally. Rifaximin is used in the treatment of traveler's diarrhea and hepatic encephalopathy.
1) Rifaximin as a gut antibiotic, rifamycin derivatives applicable to acute and chronic intestinal infections caused by Gram-positive bacteria and negative bacteria, aerobic and anaerobic bacteria, diarrhea syndrome, encephalitis, hepatic coma.
2) Rifaximin Is a highly effective and low toxicity intestinal antibiotics.